PACS vendors report record sales increases Both enterprise and miniPACS products strong Entry-level and modality-specific PACS are driving a surge in sales and installations of image-management systems in the first half of 2000,
Both enterprise and miniPACS products strong
Entry-level and modality-specific PACS are driving a surge in sales and installations of image-management systems in the first half of 2000, according to several PACS vendors. Sales of enterprise PACS remain strong as well, with hospital IT administrators becoming more involved in the buying decisionsfurther indication that this technology is finally moving into the medical mainstream.
Growing interest in smaller, modality-specific PACS is already paying off for Agfa, which introduced Impax Basix, an entry-level version of its enterprise Impax product, earlier this year (SCAN 1/12/00). Targeted for smaller or lower-volume hospitals and imaging centers, Impax Basix utilizes Impax hardware infrastructure but supports fewer modalities and displays, according to the Ridgefield Park, NJ-based company. Agfa also offers Impax for Cardiology, which is generating a lot of interest in that niche market, and displayed Impax with built-in RIS capabilities at the recent Healthcare Information and Management Systems Society meeting. Sales of its computed radiography systems are also doing better than the company had projected, which in turn are driving PACS sales.
The market is expanding a lot more rapidly than we thought, said Dean Kaufman, director of strategic marketing for Agfas Impax Solutions group. We had our best first quarter ever. Basically we did in the first quarter this year what we did in the whole first half of last year.
As of the end of 1999, Agfa claimed to have nearly 400 installed PACS worldwide.
Kaufman attributed the increase this year to the lack of Y2K concerns and a maturing of the marketplace, in addition to the expanding entry-level customer base. Buying cycles have declined from a year to around eight months, and requests for proposal volumes have remained consistent. The companys participation in the DIN-PACS project has also helped build some momentum in the military market, he added.
The technology is maturing and people are making quicker buying decisions, which could be part of the overall concept of PACS entering the mainstream, he said.
GE Medical has seen significant growth in both large-scale and entry-level PACS in the first five months of this year, according to Bruce Johnson, marketing communications manager. The company recorded a 45% increase in U.S. sales volume for PACS in the first quarter compared to the first quarter of 1999, and expects that number to increase to 65% year-to-year in the second quarter.
We have seen growth at the high end and currently have some very large ($5 million to $10 million) deals coming in, Johnson said.
The other area of expanded interest for GE is entry-level PACS and modality clusters, which help provide a starting point for customers who have been apprehensive about going filmless all at once or couldnt afford to invest in a large-scale PACS. GEs PACS/RIS integration and Web-based image-distribution capabilities are also stimulating interest from customers outside the radiology department, Johnson added.
Philips Medical Systems recorded a 200% increase in sales orders and a 300% increase in prospects for the first quarter of this year compared to the same quarter a year ago, according to Jim Champagne, director of business development and sales support for Philips Integrated Clinical Solutions group in Shelton, CT. Sales of Philips enterprise products outpaced those of its entry-level PACS, and in an increasing number of cases the final decision-makers are IT administrators rather than the traditional radiology or cardiology department heads.
We anticipate having the same kind of volume increase in the second quarter, with sales equally as strong if not stronger, Champagne said.
Like Kaufman, Champagne attributes this growth in part to pent-up demand from Y2K delays, but also credits Philips partnerships with Lucent, Force 3, TalkTech, StorageTek, and others with helping give the company greater market presence.
The PACS market is also strong for Siemens Medical this year, and the last month in particular has been a busy one for Siemens PACS business, especially among nontraditional PACS customers such as community hospitals and imaging centers that see PACS as a way to integrate horizontally with their affiliated main campuses, according to Rik Primo, director of the IS/PACS division for Siemens in Iselin, NJ. Siemens is also seeing an upswing in PACS purchases from existing customers who already have PACS capabilities in the radiology department and want to upgrade and expand into other modalities.
Just over the past month, we have been talking to a lot of PACS customers who are expanding in ways that almost equal the initial investment they made in PACS, Primo said.
The company is also optimistic about the market for its newest addition to the Sienet line of PACS products: an entry-level miniPACS called Magic Start that will be introduced at the upcoming Society for Computer Applications in Radiology (SCAR) meeting in Philadelphia.
Primo noted, however, that HIPAA concerns have delayed some buying decisions for enterprise PACS, especially among hospitals that are considering investing in this technology for the first time.
Our PACS sales are going well, but we are seeing some delays in closing deals because of HIPAAnot in the radiology department, but with regard to Web distribution and image distribution projects, he said.
Study Assesses Lung CT-Based AI Models for Predicting Interstitial Lung Abnormality
September 6th 2024A machine-learning-based model demonstrated an 87 percent area under the curve and a 90 percent specificity rate for predicting interstitial lung abnormality on CT scans, according to new research.